BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 28324150)

  • 1. Stress-stones-stress-recurrent stones: a self-propagating cycle? Difficulties in solving this dichotomy.
    Arzoz-Fabregas M; Roca-Antonio J; Ibarz-Servio L; Jappie-Mahomed D; Rodgers A
    Urolithiasis; 2017 Dec; 45(6):515-524. PubMed ID: 28324150
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chronic stress and calcium oxalate stone disease: is it a potential recurrence risk factor?
    Arzoz-Fabregas M; Ibarz-Servio L; Edo-Izquierdo S; Doladé-Botías M; Fernandez-Castro J; Roca-Antonio J
    Urolithiasis; 2013 Apr; 41(2):119-27. PubMed ID: 23503873
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in urinary parameters after oral administration of potassium-sodium citrate and magnesium oxide to prevent urolithiasis.
    Kato Y; Yamaguchi S; Yachiku S; Nakazono S; Hori J; Wada N; Hou K
    Urology; 2004 Jan; 63(1):7-11; discussion 11-2. PubMed ID: 14751336
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A study on the cause of urolithiasis of the upper urinary tract--clinical study of risk factors in the formation of stones in the upper urinary tract].
    Nonomura M; Kawamura J; Ueda M; Okada Y; Takeuchi H; Yoshida O
    Hinyokika Kiyo; 1986 Mar; 32(3):311-25. PubMed ID: 3728237
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of crystallization risk formulas in pediatric calcium stone-formers.
    Sikora P; Zajaczkowska M; Hoppe B
    Pediatr Nephrol; 2009 Oct; 24(10):1997-2003. PubMed ID: 19333626
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Stress-related alteration of urine compositions: idiopathic CaOx stone formers, patients with chronic inflammatory bowel disease (CIBD) and healthy controls].
    Berg W; Uhlemann C; Meissner A; Laube N
    Urologe A; 2011 Dec; 50(12):1606-13. PubMed ID: 21989587
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Short-Term Changes in Urinary Relative Supersaturation Predict Recurrence of Kidney Stones: A Tool to Guide Preventive Measures in Urolithiasis.
    Ferraro PM; Ticinesi A; Meschi T; Rodgers A; Di Maio F; Fulignati P; Borghi L; Gambaro G
    J Urol; 2018 Nov; 200(5):1082-1087. PubMed ID: 29940247
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is calcium oxalate nucleation in postprandial urine of males with idiopathic recurrent calcium urolithiasis related to calcium phosphate nucleation and the intensity of stone formation? Studies allowing insight into a possible role of urinary free citrate and protein.
    Schwille PO; Schmiedl A; Manoharan M
    Clin Chem Lab Med; 2004 Mar; 42(3):283-93. PubMed ID: 15080561
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fasting urinary calcium-to-creatinine and oxalate-to-creatinine ratios in dogs with calcium oxalate urolithiasis and breed-matched controls.
    Furrow E; Patterson EE; Armstrong PJ; Osborne CA; Lulich JP
    J Vet Intern Med; 2015 Jan; 29(1):113-9. PubMed ID: 25581880
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Urinary citrate excretion in children with calcium urolithiasis].
    Sikora P; Bieniaś B; Majewski M; Borzecka H; Wawrzyszuk M; Zajaczkowska M
    Przegl Lek; 2006; 63 Suppl 3():134-6. PubMed ID: 16898511
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical study on the effect of mineral waters containing bicarbonate on the risk of urinary stone formation in patients with multiple episodes of CaOx-urolithiasis.
    Karagülle O; Smorag U; Candir F; Gundermann G; Jonas U; Becker AJ; Gehrke A; Gutenbrunner C
    World J Urol; 2007 Jun; 25(3):315-23. PubMed ID: 17333204
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of factors involved in calcium stone formation.
    Abraham PA; Smith CL
    Miner Electrolyte Metab; 1987; 13(3):201-8. PubMed ID: 3627051
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is idiopathic recurrent calcium urolithiasis in males a cellular disease? Laboratory findings in plasma, urine and erythrocytes, emphasizing the absence and presence of stones, oxidative and mineral metabolism: an observational study.
    Schwille PO; Manoharan M; Schmiedl A
    Clin Chem Lab Med; 2005; 43(6):590-600. PubMed ID: 16006254
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The risk of recurrent urolithiasis in children is dependent on urinary calcium and citrate.
    DeFoor WR; Jackson E; Minevich E; Caillat A; Reddy P; Sheldon C; Asplin J
    Urology; 2010 Jul; 76(1):242-5. PubMed ID: 20110113
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolic risk factors in pediatric and adult calcium oxalate urinary stone formers: is there any difference?
    Tefekli A; Esen T; Ziylan O; Erol B; Armagan A; Ander H; Akinci M
    Urol Int; 2003; 70(4):273-7. PubMed ID: 12740490
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Calcium oxalate urolithiasis in children: urinary promoters/inhibitors and role of their ratios.
    Turudic D; Batinic D; Golubic AT; Lovric M; Milosevic D
    Eur J Pediatr; 2016 Dec; 175(12):1959-1965. PubMed ID: 27730307
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Obesity and urolithiasis: evidence of regional influences.
    Trinchieri A; Croppi E; Montanari E
    Urolithiasis; 2017 Jun; 45(3):271-278. PubMed ID: 27488444
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of the probability of stone formation (PSF) score to assess stone forming risk and treatment response in a cohort of Brazilian stone formers.
    Turney B; Robertson W; Wiseman O; Amaro CR; Leitão VA; Silva IL; Amaro JL
    Int Braz J Urol; 2014; 40(4):507-12. PubMed ID: 25251955
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Body size and 24-hour urine composition.
    Taylor EN; Curhan GC
    Am J Kidney Dis; 2006 Dec; 48(6):905-15. PubMed ID: 17162145
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical and biochemical profile of patients with "pure" uric acid nephrolithiasis compared with "pure" calcium oxalate stone formers.
    Negri AL; Spivacow R; Del Valle E; Pinduli I; Marino A; Fradinger E; Zanchetta JR
    Urol Res; 2007 Oct; 35(5):247-51. PubMed ID: 17786420
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.